DONATE TODAY
May 29, 2019

Rebound of medication abortion in Texas following updated mifepristone label

In 2013, Texas House Bill 2 (HB 2) placed restrictions on the use of medication abortion, which later were nullified with the 2016 FDA-approved mifepristone label.
Share
Facebook
LinkedIn
X

Rebound of medication abortion in Texas following updated mifepristone label

https://doi.org/10.1016/j.contraception.2019.01.001

Details
Date
May 29, 2019
Category
Abortion Care
Journal
The journal Contraception
Authors
Sarah E. Baum, Kari White, Kristine Hopkins, Joseph E. Potter, Daniel Grossman
key findings
Citation
Related Publications

Texas OB/GYNs’ Limited Access to Medications for Miscarriage Management

Abortion Care, Providers, Research Briefs, Systems of Care, Texas

“You’re Trying to Do What Now?” A Mystery Shopper Study on Judicial Bypass in Alabama, Georgia, and Mississippi

Abortion Care, Journal Articles, Mississippi/Alabama/Louisiana, Systems of Care

State-Level Abortion Bans and the OBGYN Workforce: A Review of Current Evidence

Journal Articles, Policy Analysis, Providers, Systems of Care

Toward a Crisis Pregnancy Center Client Typology: Abortion-Seekers’ Expectations and Experiences Following Implementation of Texas’ Early Abortion Ban

Abortion Care, Journal Articles, Policy Analysis, Texas